Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1

Acute myeloid leukemia (AML) with BCR-ABL1 is rare and has a poor prognosis with conventional chemotherapy or ABL tyrosine kinase inhibitors (TKIs) alone. We reported a case of AML with BCR-ABL1 patient who was successfully treated with dasatinib alone; additionally, we previously reported another c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Asako Takeuchi, Toshinori Kondo, Taizo Tasaka, Seiko Yamada, Tadashi Hirose, Hirofumi Fukuda, Risa Shimizu, Yoshiko Matsuhashi, Eisei Kondo, Hideho Wada
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-01-01
coleção:	Leukemia Research Reports
Assuntos:	Acute myeloid leukemia BCR-ABL1 Philadelphia chromosome Tyrosine kinase inhibitor
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S221304892030039X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!